Summary by Moomoo AI
Aclarion, Inc., a healthcare technology company leveraging MRS and AI for spine care optimization, reported annual revenue of $45,724 for 2024, down from $75,404 in 2023. The company recorded a net loss of $7.0 million compared to $4.9 million in the previous year, primarily due to increased operating expenses and non-cash charges related to debt conversion.The company made significant progress in strengthening its financial position through multiple capital raises. In early 2025, Aclarion successfully raised $20.1 million through a combination of public offerings and warrant exercises, including a $14.6 million underwritten public offering of units and $5.2 million in registered direct offerings. These funds will support product development, expand sales and marketing efforts, and provide working capital.Looking ahead, Aclarion believes its current cash position will fund operations...Show More
Comment(0)
Reason For Report